THYROID FUNCTION ABNORMALITIES AND LIPID PROFILE OF PATIENTS WITH METABOLIC SYNDROME: A CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.22159/ajpcr.2024v17i3.51192Keywords:
Metabolic syndrome, Thyroid function abnormalities, Dyslipidemia, Follow-upAbstract
Objective: The objective was to study the prevalence of thyroid function abnormalities and lipid profile in cases with metabolic syndrome.
Methods: We conducted this observational cross-sectional study of 80 patients with metabolic syndrome to analyze their thyroid functions and lipid profile. The study was conducted in the department of general medicine of a tertiary care medical institute. Individuals fulfilling the National Cholesterol Education Program Adult Treatment Panel III criteria for metabolic syndrome were included in this study on the basis of a predefined inclusion and exclusion criteria. Demographic details were noted. A detailed history was taken and a clinical examination was done. Thyroid function test and lipid profile were done in all cases. The presence of thyroid function and lipid profile abnormalities was analyzed. Statistical analysis was done using SPSS 21.0 software and p<0.05 was taken as statistically significant.
Results: Out of these 80 cases, there were 43 (53.75%) males and 37 (46.25%) females with a M: F ratio of 1:0.86. The mean age of male and female patients was comparable with no statistically significant difference (p=0.3739). Analysis of thyroid functions showed that 48.75% of patients were euthyroid, 35% had subclinical hypothyroidism, and 16.25% had clinical hypothyroidism. Notably, euthyroid patients had more stable lipid profiles with a total cholesterol mean of 189.45 mg/dL and triglycerides at 162.65 mg/dL. In contrast, patients with clinical hypothyroidism showed significant lipid disturbances, including total cholesterol of 249.87 mg/dL and triglycerides at 274.42 mg/dL.
Conclusion: Thyroid dysfunction and dyslipidemia are common occurrence in patients with metabolic syndrome. Also, individuals with metabolic syndrome, particularly if they have coexistent thyroid dysfunction are at increased risk of developing significant dyslipidemia. It is therefore important to monitor thyroid functions and lipid profile of individuals with metabolic syndrome.
Downloads
References
Sørensen TI, Martinez AR, Jørgensen TS. Epidemiology of obesity. Handb Exp Pharmacol. 2022;274:3-27. doi: 10.1007/164_2022_581
Ginsberg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr. 2009;4(2):113-9. doi: 10.1111/j.1559-4572.2008.00044.x
Moller DE, Kaufman KD. Metabolic syndrome: A clinical and molecular perspective. Annu Rev Med. 2005;56:45-62. doi: 10.1146/ annurev.med.56.082103.104751
Cho LW. Metabolic syndrome. Singapore Med J. 2011;52(11):779-85.
Teixeira PF, Dos Santos PB, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome. Ther Adv Endocrinol Metab. 2020;11:1-33. doi: 10.1177/2042018820917869
Rastgooye Haghi A, Solhjoo M, Tavakoli MH. Correlation between subclinical hypothyroidism and dyslipidemia. Iran J Pathol. 2017;12(2):106-11.
Ruotolo G, Howard BV. Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep. 2002;4(6):494-500. doi: 10.1007/s11886-002-0113-6
Srivastava S, Mathur G, Chauhan G, Kapoor P, Bhaskar P, Jain G, et al. Impact of thyroid dysfunction on insulin resistance: A study from a tertiary care center in India. J Assoc Physicians India. 2021;69(2):49-53.
El-Hay GA, Argoon SA, Mousa NM. Evaluation of the frequency and patterns of thyroid dysfunction in patients with metabolic syndrome. Egypt J Intern Med. 2021;33:24. doi: 10.1186/s43162-021-00054-z
Lipsy RJ. The national cholesterol education program adult treatment panel III guidelines. J Manag Care Pharm. 2003;9(1 Suppl):2-5. doi: 10.18553/jmcp.2003.9.s1.2
Shokripour M, Imanieh MH, Garayemi S, Omidifar N, Shirazi Yeganeh B, Althabhawee F. Thyroid stimulating hormone, T3 and T4 population-based reference range and children prevalence of thyroid dysfunction: First report from South of Iran. Iran J Pathol. 2022;17(4):427-34. doi: 10.30699/IJP.2022.541736.2812
Hattori T, Konno S, Munakata M. Gender differences in lifestyle factors associated with metabolic syndrome and preliminary metabolic syndrome in the general population: The Watari study. Intern Med. 2017;56(17):2253-9. doi: 10.2169/internalmedicine.8578-16
Chang SH, Chang YY, Wu LY. Gender differences in lifestyle and risk factors of metabolic syndrome: Do women have better health habits than men? J Clin Nurs. 2019;28(11-2):2225-34. doi: 10.1111/ jocn.14824
Wang WY, Li CH, Wu YS, Chien WC, Wang KY, Tzeng WC. Gender differences in the prevalence of metabolic syndrome among Taiwanese air force personnel: A population-based study. J Cardiovasc Nurs. 2020;35(5):502-11. doi: 10.1097/JCN.0000000000000714
Khatiwada S, Sah SK, Rajendra KC, Baral N, Lamsal M. Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome. Clin Diabetes Endocrinol. 2016;2:3. doi: 10.1186/s40842-016-0021-0
Deshmukh V, Farishta F, Bhole M. Thyroid dysfunction in patients with metabolic syndrome: A cross-sectional, epidemiological, Pan-India study. Int J Endocrinol. 2018;2018:2930251. doi: 10.1155/2018/2930251
Gyawali P, Takanche JS, Shrestha RK, Bhattarai P, Khanal K, Risal P, et al. Pattern of thyroid dysfunction in patients with metabolic syndrome and its relationship with components of metabolic syndrome. Diabetes Metab J. 2015;39(1):66-73. doi: 10.4093/dmj.2015.39.1.66
Abha P, Keshari JR, Sinha SR, Nishant K, Kumari R, Prakash P. Association of thyroid function with lipid profile in patients with metabolic syndrome: A prospective cross-sectional study in the Indian population. Cureus. 2023;15(9):e44745. doi: 10.7759/cureus.44745
Gutch M, Rungta S, Kumar S, Agarwal A, Bhattacharya A, Razi SM. Thyroid functions and serum lipid profile in metabolic syndrome. Biomed J. 2017;40(3):147-53. doi: 10.1016/j.bj.2016.12.006
Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76-84. doi: 10.2174/1874192401105010076
Published
How to Cite
Issue
Section
Copyright (c) 2024 TASO BEYONG, RATAN RAM
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
